Shareholder in Abeona (NASDAQ: ABEO) plans sale of 12,610 shares

Rhea-AI Filing Summary

Abeona Therapeutics (ABEO) has a holder planning to sell 12,610 shares of common stock through broker Stifel Nicolaus & Company on or about 01/22/2026 on the Nasdaq market, with an aggregate market value of $66,658.00. The notice states that there were 54,191,361 shares of this class outstanding. The shares to be sold relate to restricted stock units that were acquired from the issuer on 01/21/2026 as equity compensation, in an amount of 25,048 shares. The person filing represents that they are not aware of any undisclosed material adverse information about the issuer’s current or prospective operations.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Stifel Nicolaus & Company Inc 501 N Broadway St. Louis MO 63102	12610	66658.00	54191361	01/22/2026	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	01/21/2026	Restricted Stock Units	Issuer			25048	01/21/2026	Equity Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 filing for ABEO disclose?

The Form 144 for ABEO discloses that a holder intends to sell 12,610 shares of Abeona Therapeutics common stock on or about 01/22/2026 through Stifel Nicolaus & Company on the Nasdaq market.

How many ABEO shares are planned to be sold and what is their market value?

The planned sale involves 12,610 shares of Abeona common stock with an aggregate market value of $66,658.00, based on the price used in the notice.

How many Abeona Therapeutics (ABEO) shares are outstanding according to this notice?

The notice states that there are 54,191,361 shares of Abeona Therapeutics common stock outstanding for the class referenced.

How were the ABEO shares being sold originally acquired?

The securities relate to restricted stock units in Abeona common stock that were acquired from the issuer on 01/21/2026, with 25,048 shares acquired as equity compensation.

Which broker will handle the planned ABEO share sale?

The planned sale of Abeona Therapeutics common stock is to be executed through Stifel Nicolaus & Company Inc., located at 501 N Broadway, St. Louis, MO 63102.

What representation does the selling holder make in this ABEO Form 144?

The selling holder represents that they do not know of any material adverse information about Abeona’s current or prospective operations that has not been publicly disclosed.